Accepted for Publication: July 26, 2022.
Published Online: October 26, 2022. doi:10.1001/jamadermatol.2022.3911
Corresponding Author: John S. Barbieri, MD, MBA, Department of Dermatology, Brigham and Women’s Hospital, 41 Avenue Louis Pasteur, Boston, MA 02115 (jbarbieri@bwh.harvard.edu).
Author Contributions: Ms Ly and Mr Miller had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Ms Ly and Mr Miller contributed equally to this study.
Concept and design: Ly, Miller, Mostaghimi, Barbieri.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ly, Miller, Tong, Blake, Barbieri.
Critical revision of the manuscript for important intellectual content: Ly, Miller, Mostaghimi, Barbieri.
Statistical analysis: Ly, Miller, Barbieri.
Administrative, technical, or material support: Miller, Blake, Mostaghimi.
Supervision: Mostaghimi, Barbieri.
Conflict of Interest Disclosures: Dr Mostaghimi reported receiving personal fees from hims & hers, Figure Co, ACOM, Digital Diagnostics, Concert, Pfizer, Eli Lilly and Company, AbbVie, Equillium, and Boehringer Ingelheim outside the submitted work; and serves as an Associate Editor for JAMA Dermatology. Dr Barbieri serves as an Associate Editor for JAMA Dermatology. No other disclosures were reported.
Disclaimer: Drs Mostaghimi and Barbieri are Associate Editors of JAMA Dermatology but were not involved in any of the decisions regarding review of the manuscript or its acceptance.
1.Barbieri
JS , Fulton
R , Neergaard
R , Nelson
MN , Barg
FK , Margolis
DJ . Patient perspectives on the lived experience of acne and its treatment among adult women with acne: a qualitative study.
JAMA Dermatol. 2021;157(9):1040-1046. doi:
10.1001/jamadermatol.2021.2185
PubMedGoogle ScholarCrossref 2.Abram
K , Silm
H , Maaroos
HI , Oona
M . Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea.
Acta Derm Venereol. 2009;89(5):488-491. doi:
10.2340/00015555-0716
PubMedGoogle ScholarCrossref 3.Stuart
B , Maund
E , Wilcox
C ,
et al. Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
Br J Dermatol. 2021;185(3):512-525. doi:
10.1111/bjd.20080
PubMedGoogle ScholarCrossref 6.Schmitt
J , Deckert
S , Alam
M ,
et al. Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).
Br J Dermatol. 2016;174(2):287-295. doi:
10.1111/bjd.14337
PubMedGoogle ScholarCrossref 7.Perez-Chada
L , Taliercio
VL , Gottlieb
A ,
et al. Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders: on behalf of International Dermatology Outcome Measures and the American Academy of Dermatology.
J Am Acad Dermatol. 2019;S0190-9622(19):32745-32748. doi:
10.1016/j.jaad.2019.09.008
PubMedGoogle ScholarCrossref 11.Lefebvre
C , Glanville
J , Briscoe
S ,
et al. Chapter 4: searching for and selecting studies. In: Higgins
JPT , Thomas
J , Chandler
J ,
et al, eds.
Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; 2022. Accessed August 15, 2022.
https://training.cochrane.org/handbook/current/chapter-04 13.Baumann
L , Goldberg
DJ , Stein Gold
L ,
et al. Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: findings from the second REVEAL trial.
J Drugs Dermatol. 2018;17(3):290-298.
PubMedGoogle Scholar 14.Bribeche
MR , Fedotov
VP , Gladichev
VV , Pukhalskaya
DM , Kolitcheva
NL . Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea.
Int J Dermatol. 2015;54(4):481-487. doi:
10.1111/ijd.12552
PubMedGoogle ScholarCrossref 15.Cao
T , Tan
ES , Chan
YH , Yosipovitch
G , Tey
HL . Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: a randomized single-blinded pilot study.
Indian J Dermatol Venereol Leprol. 2018;84(4):458-460. doi:
10.4103/ijdvl.IJDVL_41_17
PubMedGoogle ScholarCrossref 16.Chilicka
K , Rogowska
AM , Szyguła
R , Taradaj
J . Examining quality of life after treatment with azelaic and pyruvic acid peels in women with acne vulgaris.
Clin Cosmet Investig Dermatol. 2020;13:469-477. doi:
10.2147/CCID.S262691
PubMedGoogle ScholarCrossref 17.Fowler
J , Jarratt
M , Moore
A ,
et al; Brimonidine Phase II Study Group. Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.
Br J Dermatol. 2012;166(3):633-641. doi:
10.1111/j.1365-2133.2011.10716.x
PubMedGoogle ScholarCrossref 18.Kircik
LH , DuBois
J , Draelos
ZD ,
et al. Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: findings from the first REVEAL trial.
J Drugs Dermatol. 2018;17(1):97-105.
PubMedGoogle Scholar 19.Layton
AM , Schaller
M , Homey
B ,
et al. Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
J Eur Acad Dermatol Venereol. 2015;29(12):2405-2410. doi:
10.1111/jdv.13305
PubMedGoogle ScholarCrossref 20.Luger
T , Peukert
N , Rother
M . A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea.
J Eur Acad Dermatol Venereol. 2015;29(2):283-290. doi:
10.1111/jdv.12520
PubMedGoogle ScholarCrossref 21.Mohammadi
S , Badakhsh
H , Pardakhti
A ,
et al. Evaluation of efficacy of niosomal clindamycin phosphate 1% solution in comparison to conventional clindamycin phosphate 1% solution in the treatment of acne vulgaris: a randomized controlled trial.
J Pak Assoc Dermatol. 2020;30(1):64-71.
Google Scholar 23.Schlessinger
J , Lupin
M , McDaniel
D , George
R . Safety and effectiveness of microfocused ultrasound for treating erythematotelangiectatic rosacea.
J Drugs Dermatol. 2019;18(6):522.
PubMedGoogle Scholar 24.Taieb
A , Passeron
T , Ruzicka
T ,
et al. Ivermectin cream improves health-related quality of life in patients with rosacea: data from a randomized trial.
Br J Dermatol. 2016;175(6):1366-1368. doi:
10.1111/bjd.14665
PubMedGoogle ScholarCrossref 25.van der Linden
MMD , van Ratingen
AR , van Rappard
DC , Nieuwenburg
SA , Spuls
PI . DOMINO, doxycycline 40 mg vs minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.
Br J Dermatol. 2017;176(6):1465-1474. doi:
10.1111/bjd.15155
PubMedGoogle ScholarCrossref 26.Schaller
M , Kemény
L , Havlickova
B ,
et al. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
J Am Acad Dermatol. 2020;82(2):336-343. doi:
10.1016/j.jaad.2019.05.063PubMedGoogle ScholarCrossref 28.Seo
HM , Kim
JI , Kim
HS , Choi
YJ , Kim
WS . Prospective comparison of dual wavelength long-pulsed 755-nm alexandrite/1,064-nm neodymium:yttrium-aluminum-garnet laser versus 585-nm pulsed dye laser treatment for rosacea.
Ann Dermatol. 2016;28(5):607-614. doi:
10.5021/ad.2016.28.5.607PubMedGoogle ScholarCrossref 29.Gold
LS , Del Rosso
JQ , Kircik
L ,
et al. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
J Am Acad Dermatol. 2020;82(5):1166-1173. doi:
10.1016/j.jaad.2020.01.043PubMedGoogle ScholarCrossref 30.Gold
LS , Dhawan
S , Weiss
J , Draelos
ZD , Ellman
H , Stuart
IA . A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.
J Am Acad Dermatol. 2019;80(1):168-177. doi:
10.1016/j.jaad.2018.08.020PubMedGoogle ScholarCrossref 33.Bissonnette
R , Poulin
Y , Drew
J , Hofland
H , Tan
J . Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.
J Am Acad Dermatol. 2017;76(1):33-39. doi:
10.1016/j.jaad.2016.08.053PubMedGoogle ScholarCrossref 34.Di Nardo
A , Holmes
AD , Muto
Y ,
et al. Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial.
J Am Acad Dermatol. 2016;74(6):1086-1092. doi:
10.1016/j.jaad.2016.01.023PubMedGoogle ScholarCrossref 35.Shemer
A , Shiri
J , Mashiah
J , Farhi
R , Gupta
AK . Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
J Am Acad Dermatol. 2016;74(6):1251-1252. doi:
10.1016/j.jaad.2015.09.065PubMedGoogle ScholarCrossref 37.Dréno
B , Kaufmann
R , Talarico
S ,
et al. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Br J Dermatol. 2011;165(2):383-390. doi:
10.1111/j.1365-2133.2011.10374.xPubMedGoogle ScholarCrossref 38.Kwon
HH , Lee
JB , Yoon
JY ,
et al. The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial.
Br J Dermatol. 2013;168(5):1088-1094. doi:
10.1111/bjd.12186PubMedGoogle ScholarCrossref 39.Webster
G , Draelos
ZD , Graber
E ,
et al. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.
Br J Dermatol. 2020;183(3):471-479. doi:
10.1111/bjd.18857PubMedGoogle ScholarCrossref 40.Poulin
Y , Sanchez
NP , Bucko
A ,
et al. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
Br J Dermatol. 2011;164(6):1376-1382. doi:
10.1111/j.1365-2133.2011.10344.xPubMedGoogle ScholarCrossref 41.Pariser
DM , Eichenfield
LF , Bukhalo
M , Waterman
G , Jarratt
M ; PDT Study Group. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
Br J Dermatol. 2016;174(4):770-777. doi:
10.1111/bjd.14345PubMedGoogle ScholarCrossref 42.Taieb
A , Ortonne
JP , Ruzicka
T ,
et al; Ivermectin Phase III study group. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Br J Dermatol. 2015;172(4):1103-1110. doi:
10.1111/bjd.13408PubMedGoogle ScholarCrossref 43.Tan
J , Humphrey
S , Vender
R ,
et al; POWER study group. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
Br J Dermatol. 2014;171(6):1508-1516. doi:
10.1111/bjd.13191PubMedGoogle ScholarCrossref 44.Kawashima
M , Hashimoto
H , Alió Sáenz
AB , Ono
M , Yamada
M . Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Br J Dermatol. 2015;172(2):494-503. doi:
10.1111/bjd.13265PubMedGoogle ScholarCrossref 45.Trifu
V , Tiplica
GS , Naumescu
E , Zalupca
L , Moro
L , Celasco
G . Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
Br J Dermatol. 2011;165(1):177-183. doi:
10.1111/j.1365-2133.2011.10332.xPubMedGoogle ScholarCrossref 46.Paithankar
DY , Sakamoto
FH , Farinelli
WA ,
et al. Acne treatment based on selective photothermolysis of sebaceous follicles with topically delivered light-absorbing gold microparticles.
J Invest Dermatol. 2015;135(7):1727-1734. doi:
10.1038/jid.2015.89PubMedGoogle ScholarCrossref 47.Stein Gold
L , Weiss
J , Rueda
MJ , Liu
H , Tanghetti
E . Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3 %/benzoyl peroxide 2.5 % gel: a randomized, double-blind, parallel-group, controlled study.
Am J Clin Dermatol. 2016;17(3):293-303. doi:
10.1007/s40257-016-0178-4PubMedGoogle ScholarCrossref 48.Stein Gold
L , Baldwin
H , Kircik
LH ,
et al. Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug.
Am J Clin Dermatol. 2022;23(1):93-104. doi:
10.1007/s40257-021-00650-3PubMedGoogle ScholarCrossref 49.Mrowietz
U , Kedem
TH , Keynan
R ,
et al. A phase II, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular rosacea.
Am J Clin Dermatol. 2018;19(3):427-436. doi:
10.1007/s40257-017-0339-0PubMedGoogle ScholarCrossref 51.Thielitz
A , Lux
A , Wiede
A , Kropf
S , Papakonstantinou
E , Gollnick
H . A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.
J Eur Acad Dermatol Venereol. 2015;29(4):789-796. doi:
10.1111/jdv.12823PubMedGoogle ScholarCrossref 53.Bouloc
A , Roo
E , Imko-Walczuk
B , Moga
A , Chadoutaud
B , Dréno
B . A skincare combined with combination of adapalene and benzoyl peroxide provides a significant adjunctive efficacy and local tolerance benefit in adult women with mild acne.
J Eur Acad Dermatol Venereol. 2017;31(10):1727-1731. doi:
10.1111/jdv.14379PubMedGoogle ScholarCrossref 54.Xu
JH , Lu
QJ , Huang
JH ,
et al. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
J Eur Acad Dermatol Venereol. 2016;30(7):1176-1182. doi:
10.1111/jdv.13622PubMedGoogle ScholarCrossref 55.Schaller
M , Sebastian
M , Ress
C , Seidel
D , Hennig
M . A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
J Eur Acad Dermatol Venereol. 2016;30(6):966-973. doi:
10.1111/jdv.13541PubMedGoogle ScholarCrossref 56.Guo
K , Zhu
D , Lu
Z , Pan
Y , Deng
H . Effect of minocycline hydrochloride combined with photodynamic therapy on skin barrier function of patients with acne.
Am J Transl Res. 2021;13(7):8427-8432.
PubMedGoogle Scholar 57.Ibrahim
SM , Farag
A , Hegazy
R , Mongy
M , Shalaby
S , Kamel
MM . Combined low-dose isotretinoin and pulsed dye laser versus standard-dose isotretinoin in the treatment of inflammatory acne.
Lasers Surg Med. 2021;53(5):603-609. doi:
10.1002/lsm.23356PubMedGoogle ScholarCrossref 58.Ahn
GR , Kim
JM , Park
SJ , Li
K , Kim
BJ . Selective sebaceous gland electrothermolysis using a single microneedle radiofrequency device for acne patients: a prospective randomized controlled study.
Lasers Surg Med. 2020;52(5):396-401. doi:
10.1002/lsm.23152PubMedGoogle ScholarCrossref 59.Wu
HE , Liu
YB , Cui
L , Xu
GJ , Sun
XD . Three-step irradiance schedule versus two-step irradiance schedule for pain control during topical 5-aminolevulinic acid-photodynamic therapy of facial acne in Chinese patients: a prospective randomized comparative study.
Lasers Surg Med. 2022;54(2):224-229. doi:
10.1002/lsm.23464PubMedGoogle ScholarCrossref 60.Nitayavardhana
S , Manuskiatti
W , Cembrano
KAG , Wanitphadeedecha
R . A comparative study between once-weekly and alternating twice-weekly regimen using blue (470 nm) and red (640 nm) light combination led phototherapy for moderate-to-severe acne vulgaris.
Lasers Surg Med. 2021;53(8):1080-1085. doi:
10.1002/lsm.23388PubMedGoogle ScholarCrossref 61.Hayashi
N , Kurokawa
I , Siakpere
O ,
et al. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
J Dermatol. 2018;45(8):951-962. doi:
10.1111/1346-8138.14497PubMedGoogle ScholarCrossref 62.Chottawornsak
N , Chongpison
Y , Asawanonda
P , Kumtornrut
C . Topical 2% ketoconazole cream monotherapy significantly improves adult female acne: A double-blind, randomized placebo-controlled trial.
J Dermatol. 2019;46(12):1184-1189. doi:
10.1111/1346-8138.15113PubMedGoogle ScholarCrossref 65.Kwon
HH , Moon
KR , Park
SY , Yoon
JY , Suh
DH , Lee
JB . Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: A double-blind randomized controlled trial.
J Dermatol. 2016;43(5):515-521. doi:
10.1111/1346-8138.13191PubMedGoogle ScholarCrossref 66.Patiyasikunt
M , Chancheewa
B , Asawanonda
P , Noppakun
N , Kumtornrut
C . Efficacy and tolerability of low-dose spironolactone and topical benzoyl peroxide in adult female acne: A randomized, double-blind, placebo-controlled trial.
J Dermatol. 2020;47(12):1411-1416. doi:
10.1111/1346-8138.15559PubMedGoogle ScholarCrossref 67.Kawashima
M , Sato
S , Furukawa
F ,
et al. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
J Dermatol. 2017;44(7):774-782. doi:
10.1111/1346-8138.13798PubMedGoogle ScholarCrossref 68.Kawashima
M , Hashimoto
H , Alio Sáenz
AB , Ono
M , Yamada
M . Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in Japanese patients? A multicenter, randomized, double-blind, vehicle-controlled, parallel-group study.
J Dermatol. 2014;41(9):795-801. doi:
10.1111/1346-8138.12580PubMedGoogle ScholarCrossref 73.Mohammadi
S , Pardakhty
A , Khalili
M ,
et al. Niosomal benzoyl peroxide and clindamycin lotion versus niosomal clindamycin lotion in treatment of acne vulgaris: a randomized clinical trial.
Adv Pharm Bull. 2019;9(4):578-583. doi:
10.15171/apb.2019.066PubMedGoogle ScholarCrossref 74.Luo
Y , Luan
XL , Zhang
JH , Wu
LX , Zhou
N . Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm-wavelength intense pulsed light: A prospective randomized controlled trial with a 2-year follow-up.
Exp Ther Med. 2020;19(6):3543-3550. doi:
10.3892/etm.2020.8617PubMedGoogle ScholarCrossref 79.Brodell
RT , Schlosser
BJ , Rafal
E ,
et al. A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.
J Dermatolog Treat. 2012;23(1):26-34. doi:
10.3109/09546634.2011.643221PubMedGoogle ScholarCrossref 80.Abdel Hay
R , Hegazy
R , Abdel Hady
M , Saleh
N . Clinical and dermoscopic evaluation of combined (salicylic acid 20% and azelaic acid 20%) versus trichloroacetic acid 25% chemical peel in acne: an RCT.
J Dermatolog Treat. 2019;30(6):572-577. doi:
10.1080/09546634.2018.1484876PubMedGoogle ScholarCrossref 81.Dogra
S , Sumathy
TK , Nayak
C ,
et al. Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study.
J Dermatolog Treat. 2021;32(8):925-933. doi:
10.1080/09546634.2020.1720579PubMedGoogle ScholarCrossref 84.Chularojanamontri
L , Tuchinda
P , Kulthanan
K , Varothai
S , Winayanuwattikun
W . A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.
J Dermatolog Treat. 2016;27(2):140-145. doi:
10.3109/09546634.2015.1079298PubMedGoogle ScholarCrossref 85.Lee
HE , Ko
JY , Kim
YH ,
et al. A double-blind randomized controlled comparison of APDDR-0901, a novel cosmeceutical formulation, and 0.1% adapalene gel in the treatment of mild-to-moderate acne vulgaris.
Eur J Dermatol. 2011;21(6):959-965. doi:
10.1684/ejd.2011.1546PubMedGoogle ScholarCrossref 86.Tan
J , Bissonnette
R , Gratton
D , Kerrouche
N , Canosa
JM . The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.
Eur J Dermatol. 2018;28(4):502-508. doi:
10.1684/ejd.2018.3367PubMedGoogle ScholarCrossref 87.Dréno
B , Bettoli
V , Ochsendorf
F ,
et al. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies.
Eur J Dermatol. 2014;24(2):201-209. doi:
10.1684/ejd.2014.2293PubMedGoogle ScholarCrossref 88.Liu
LH , Fan
X , An
YX , Zhang
J , Wang
CM , Yang
RY . Randomized trial of three phototherapy methods for the treatment of acne vulgaris in Chinese patients.
Photodermatol Photoimmunol Photomed. 2014;30(5):246-253. doi:
10.1111/phpp.12098PubMedGoogle ScholarCrossref 90.Li
Y , Zhu
J , Zhang
Y , Liu
X , Ye
J . Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects.
Lasers Med Sci. 2021;36(3):657-665. doi:
10.1007/s10103-020-03113-zPubMedGoogle ScholarCrossref 92.Kim
TI , Ahn
HJ , Kang
IH , Jeong
KH , Kim
NI , Shin
MK . Nonablative fractional laser-assisted daylight photodynamic therapy with topical methyl aminolevulinate for moderate to severe facial acne vulgaris: Results of a randomized and comparative study.
Photodermatol Photoimmunol Photomed. 2017;33(5):253-259. doi:
10.1111/phpp.12312PubMedGoogle ScholarCrossref 93.Nicklas
C , Rubio
R , Cárdenas
C , Hasson
A . Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial.
Photodermatol Photoimmunol Photomed. 2019;35(1):3-10. doi:
10.1111/phpp.12413PubMedGoogle ScholarCrossref 94.Mei
X , Shi
W , Piao
Y . Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light in Chinese acne vulgaris patients.
Photodermatol Photoimmunol Photomed. 2013;29(2):90-96. doi:
10.1111/phpp.12031PubMedGoogle ScholarCrossref 95.Jaisamrarn
U , Santibenchakul
S . A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial.
Contracept Reprod Med. 2018;3(1):5. doi:
10.1186/s40834-018-0058-9PubMedGoogle ScholarCrossref 97.Bertolani
MB , Rodighiero
E , Gandolfi
M ,
et al. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
Dermatol Ther. 2021;34(1):e14724. doi:
10.1111/dth.14724PubMedGoogle ScholarCrossref 98.Cameli
N , Mariano
M , Zanniello
R , Berardesca
E . Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti-inflammatory 8-beta glycyrrhetinic acid cream for the treatment of erythema in rosacea.
Dermatol Ther. 2020;33(6):e14224. doi:
10.1111/dth.14224PubMedGoogle ScholarCrossref 99.Shie Morteza
M , Hayati
Z , Namazi
N , Abdollahimajd
F . Efficacy and safety of oral silymarin in comparison with oral doxycycline and their combination therapy in the treatment of acne vulgaris.
Dermatol Ther. 2019;32(6):e13095. doi:
10.1111/dth.13095PubMedGoogle ScholarCrossref 103.Chan
H , Chan
G , Santos
J , Dee
K , Co
JK . A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.
Int J Dermatol. 2017;56(6):686-690. doi:
10.1111/ijd.13607PubMedGoogle ScholarCrossref 105.Guertler
A , Jøntvedt
NM , Clanner-Engelshofen
BM , Cappello
C , Sager
A , Reinholz
M . Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
J Cosmet Dermatol. 2020;19(10):2627-2633. doi:
10.1111/jocd.13591PubMedGoogle ScholarCrossref 107.Kumtornrut
C , Manabe
SD , Navapongsiri
M ,
et al. A cleanser formulated with Tris (hydroxymethyl) aminomethane and l-arginine significantly improves facial acne in male Thai subjects.
J Cosmet Dermatol. 2020;19(4):901-909. doi:
10.1111/jocd.13087PubMedGoogle ScholarCrossref 109.Lee
HJ , Kim
JY , Park
KD , Lee
WJ . Randomized controlled double-blind study of a cleanser composed of 5-aminolevulinic acid and peptides on mild and moderate acne vulgaris.
J Cosmet Dermatol. 2020;19(7):1745-1750. doi:
10.1111/jocd.13232PubMedGoogle ScholarCrossref 110.Rokni
GR , Mohammadnezhad
F , Saeedi
M ,
et al. Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-blinded, active-controlled trial.
J Cosmet Dermatol. 2021;20(11):3580-3585. doi:
10.1111/jocd.14462PubMedGoogle ScholarCrossref 112.Cestone
E , Michelotti
A , Zanoletti
V , Zanardi
A , Mantegazza
R , Dossena
M . Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.
J Cosmet Dermatol. 2017;16(2):265-270. doi:
10.1111/jocd.12309PubMedGoogle ScholarCrossref 114.Dayal
S , Kalra
KD , Sahu
P . Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris.
J Cosmet Dermatol. 2020;19(2):393-399. doi:
10.1111/jocd.13168PubMedGoogle ScholarCrossref 115.Dayal
S , Amrani
A , Sahu
P , Jain
VK . Jessner’s solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris.
J Cosmet Dermatol. 2017;16(1):43-51. doi:
10.1111/jocd.12266PubMedGoogle ScholarCrossref 116.Tirado-Sánchez
A , Espíndola
YS , Ponce-Olivera
RM , Bonifaz
A . Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
J Cosmet Dermatol. 2013;12(2):103-107. doi:
10.1111/jocd.12031PubMedGoogle ScholarCrossref 118.Luo
Y , Luan
XL , Sun
YJ , Zhang
L , Zhang
JH . Effect of recombinant bovine basic fibroblast growth factor gel on repair of rosacea skin lesions: A randomized, single-blind and vehicle-controlled study.
Exp Ther Med. 2019;17(4):2725-2733. doi:
10.3892/etm.2019.7258PubMedGoogle ScholarCrossref 119.Babaeinejad
S , Khodaeiani
E , Fouladi
RF . Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?
J Dermatolog Treat. 2011;22(4):206-210. doi:
10.3109/09546631003762639PubMedGoogle ScholarCrossref 120.Ianosi
S , Neagoe
D , Calbureanu
M , Ianosi
G . Investigator-blind, placebo-controlled, randomized comparative study on combined vacuum and intense pulsed light versus intense pulsed light devices in both comedonal and papulopustular acne.
J Cosmet Laser Ther. 2013;15(5):248-254. doi:
10.3109/14764172.2013.814464PubMedGoogle ScholarCrossref 121.Dayal
S , Singh
S , Sahu
P . Efficacy and safety of 25% trichloroacetic acid peel versus 30% salicylic acid peel in mild-to-moderate acne vulgaris: a comparative study.
Dermatol Pract Concept. 2021;11(3):e2021063. doi:
10.5826/dpc.1103a63PubMedGoogle ScholarCrossref 122.Xu
X , Zheng
Y , Zhao
Z , Zhang
X , Liu
P , Li
C . Efficacy of photodynamic therapy combined with minocycline for treatment of moderate to severe facial acne vulgaris and influence on quality of life.
Medicine (Baltimore). 2017;96(51):e9366. doi:
10.1097/MD.0000000000009366PubMedGoogle ScholarCrossref 124.Shahmoradi
Z , Iraji
F , Siadat
AH , Ghorbaini
A . Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial.
J Res Med Sci. 2013;18(2):115-117.
PubMedGoogle Scholar 126.Veraldi
S , Micali
G , Berardesca
E , Dall’Oglio
F , Sinagra
JL , Guanziroli
E . Results of a multicenter, randomized, controlled trial of a hydrogen peroxide-based kit versus a benzoyl peroxide-based kit in mild-to-moderate acne.
J Clin Aesthet Dermatol. 2016;9(10):50-54.
PubMedGoogle Scholar 127.Tsianakas
A , Bhatia
N , Alikunju
S ,
et al. DFD-29, a low dose oral minocycline, demonstrates superior efficacy as compared to placebo and Oraycea capsules (doxycycline HCl) in subjects with papulopustular rosacea.
Skin J Cutan Med. 2019;3:S11. doi:
10.25251/skin.3.supp.11Google ScholarCrossref 128.Alexis
A , Del Rosso
JQ , Desai
SR ,
et al. BPX-01 minocycline topical gel shows promise for the treatment of moderate-to-severe inflammatory acne vulgaris.
J Clin Aesthet Dermatol. 2018;11(11):25-35.
PubMedGoogle Scholar 130.Sitohang
IBS , Yahya
YF , Simanungkalit
R , Adi Winarni
DR , Madjid
A . Efficacy and tolerability of topical nicotinamide plus antibacterial adhesive agents and zinc-pyrrolidone carboxylic acid versus placebo as an adjuvant treatment for moderate acne vulgaris in indonesia: a multicenter, double-blind, randomized, controlled trial.
J Clin Aesthet Dermatol. 2020;13(7):27-31.
PubMedGoogle Scholar 131.Nestor
MS , Swenson
N , Macri
A , Manway
M , Paparone
P . Efficacy and tolerability of a combined 445nm and 630nm over-the-counter light therapy mask with and without topical salicylic acid versus topical benzoyl peroxide for the treatment of mild-to-moderate acne vulgaris.
J Clin Aesthet Dermatol. 2016;9(3):25-35.
PubMedGoogle Scholar 132.Baldwin
H , Blanco
D , McKeever
C ,
et al. Results of a phase 2 efficacy and safety study with SB204, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris.
J Clin Aesthet Dermatol. 2016;9(8):12-18.
PubMedGoogle Scholar 133.Eichenfield
LF , Lain
T , Frankel
EH ,
et al. Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: second of two identically designed, large, multicenter, randomized, vehicle-controlled trials.
J Drugs Dermatol. 2016;15(8):962-969.
PubMedGoogle Scholar 134.Feldman
SR , Werner
CP , Alió Saenz
AB . The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
J Drugs Dermatol. 2013;12(4):438-446.
PubMedGoogle Scholar 136.Tanghetti
EA , Kircik
LH , Green
LJ ,
et al. a phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a novel tazarotene 0.045% lotion and tazarotene 0.1% cream in the treatment of moderate-to-severe acne vulgaris.
J Drugs Dermatol. 2019;18(6):542-542.
PubMedGoogle Scholar 137.Stein
L , Kircik
L , Fowler
J ,
et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
J Drugs Dermatol. 2014;13(3):316-323.
PubMedGoogle Scholar 138.Pariser
DM , Rich
P , Cook-Bolden
FE , Korotzer
A . An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
J Drugs Dermatol. 2014;13(9):1083-1089.
PubMedGoogle Scholar 139.Palli
MB , Reyes-Habito
CM , Lima
XT , Kimball
AB . A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.
J Drugs Dermatol. 2013;12(6):633-637.
PubMedGoogle Scholar 140.Gold
LS , Papp
K , Lynde
C ,
et al. Treatment of rosacea with concomitant use of topical ivermectin 1% cream and brimonidine 0.33% gel: a randomized, vehicle-controlled study.
J Drugs Dermatol. 2017;16(9):909-916.
PubMedGoogle Scholar 141.Tyring
SK , Kircik
LH , Pariser
DM , Guenin
E , Bhatt
V , Pillai
R . Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of efficacy and safety in patients aged 9 years and older.
J Drugs Dermatol. 2018;17(10):1084-1091.
PubMedGoogle Scholar 142.Eichenfield
LF , Draelos
Z , Lucky
AW ,
et al. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
J Drugs Dermatol. 2013;12(6):611-618.
PubMedGoogle Scholar 143.Takigawa
M , Tokura
Y , Shimada
S , Furukawa
F , Noguchi
N , Ito
T ; Acne Study Group. Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.
J Dermatol. 2013;40(8):620-625. doi:
10.1111/1346-8138.12189PubMedGoogle ScholarCrossref 144.Moore
A , Ling
M , Bucko
A , Manna
V , Rueda
MJ . Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study.
J Drugs Dermatol. 2015;14(6):581-586.
PubMedGoogle Scholar 145.Webster
GF , Leyden
JJ , Gross
JA . Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
J Drugs Dermatol. 2014;13(6):665-670.
PubMedGoogle Scholar 146.Rosso
JQ , Draelos
ZD , Effron
C , Kircik
LH . Oral sarecycline for treatment of papulopustular rosacea: results of a pilot study of effectiveness and safety.
J Drugs Dermatol. 2021;20(4):426-431. doi:
10.36849/JDD.5923PubMedGoogle ScholarCrossref 147.Moore
A , Green
LJ , Bruce
S ,
et al. Once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical trials.
J Drugs Dermatol. 2018;17(9):987-996.
PubMedGoogle Scholar 148.Leyden
JJ . Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
J Drugs Dermatol. 2011;10(10):1179-1185.
PubMedGoogle Scholar 149.Santos-Caetano
JP , Cargill
MR . A randomized controlled tolerability study to evaluate reformulated benzoyl peroxide face washes for acne vulgaris.
J Drugs Dermatol. 2019;18(4):350-356.
PubMedGoogle Scholar 150.Chang
ALS , Alora-Palli
M , Lima
XT ,
et al. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
J Drugs Dermatol. 2012;11(3):333-339.
PubMedGoogle Scholar 152.Leyden
JJ , Sniukiene
V , Berk
DR , Kaoukhov
A . Efficacy and safety of sarecycline, a novel, once-daily, narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris: results of a phase 2, dose-ranging study.
J Drugs Dermatol. 2018;17(3):333-338.
PubMedGoogle Scholar 153.DuBois
J , Dover
JS , Jones
TM , Weiss
RA , Berk
DR , Ahluwalia
G . Phase 2 randomized, dose-ranging study of oxymetazoline cream for treatment of persistent facial erythema associated with rosacea.
J Drugs Dermatol. 2018;17(3):308-316.
PubMedGoogle Scholar 154.Stein Gold
LF , Jarratt
MT , Bucko
AD ,
et al. Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: first of two identically designed, large, multicenter, randomized, vehicle-controlled trials.
J Drugs Dermatol. 2016;15(5):553-561.
PubMedGoogle Scholar 155.Eichenfield
LF , Gold
LS , Nahm
WK , Cook-Bolden
FE , Pariser
DM . Results of a phase 2, randomized,vehicle-controlled study evaluating the efficacy,tolerability, and safety of daily or twice daily sb204 for the treatment of acne vulgaris.
J Drugs Dermatol. 2016;15(12):1496-15027.
PubMedGoogle Scholar 156.Faghihi
G , Khosravani
P , Nilforoushzadeh
MA ,
et al. Dapsone gel in the treatment of papulopustular rosacea: a double-blind randomized clinical trial.
J Drugs Dermatol. 2015;14(6):602-606.
PubMedGoogle Scholar 157.Weiss
J , Stein Gold
L , Leoni
M , Rueda
MJ , Liu
H , Tanghetti
E . Customized single-agent therapy management of severe inflammatory acne: a randomized, double-blind, parallel-group, controlled study of a new treatment—adapalene 0.3%-benzoyl peroxide 2.5% gel.
J Drugs Dermatol. 2015;14(12):1427-1435.
PubMedGoogle Scholar 158.Leyden
JJ . Randomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel.
J Drugs Dermatol. 2014;13(6):685-688.
PubMedGoogle Scholar 159.Leyden
JJ , Bruce
S , Lee
CS ,
et al. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
J Drugs Dermatol. 2013;12(6):658-663.
PubMedGoogle Scholar 160.Jackson
JM , Kircik
LH , Lorenz
DJ . Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.
J Drugs Dermatol. 2013;12(3):292-298.
PubMedGoogle Scholar 161.Freeman
SA , Moon
SD , Spencer
JM . Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial.
J Drugs Dermatol. 2012;11(12):1410-1414.
PubMedGoogle Scholar 162.Eichenfield
LF , Alió Sáenz
AB . Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
J Drugs Dermatol. 2011;10(12):1382-1396.
PubMedGoogle Scholar 163.Tanghetti
E , Dhawan
S , Green
L ,
et al. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
J Drugs Dermatol. 2011;10(7):783-792.
PubMedGoogle Scholar 164.Kim
JH , Oh
YW , Kim
DH , Seo
BH , Suh
HS , Choi
YS . A randomized, placebo-controlled trial of gamma linolenic acid as an add-on therapy to minocycline for the treatment of rosacea.
Ann Dermatol. 2020;32(6):466-472. doi:
10.5021/ad.2020.32.6.466PubMedGoogle ScholarCrossref 165.Deshmukh
SN , Badar
VA , Mahajan
MM , Dudhgaonkar
DS , Mishra
D . Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne.
Perspect Clin Res. 2018;9(4):161-164. doi:
10.4103/picr.PICR_109_17PubMedGoogle Scholar 166.Choudhury
S , Chatterjee
S , Sarkar
DK , Dutta
RN . Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial.
Indian J Pharmacol. 2011;43(6):628-631. doi:
10.4103/0253-7613.89815PubMedGoogle Scholar 167.Massi
MN , Yunus
M , Anwar
AI ,
et al. The effectiveness of autologous serum and single-dose oral doxycycline in the treatment of acne vulgaris: a pilot clinical trial.
Open Access Maced J Med Sci. 2021;9(B):1602-1606. doi:
10.3889/oamjms.2021.6874Google ScholarCrossref 168.Van
TN , Thi
LD , Trong
HN ,
et al. Efficacy of oral isotretinoin in combination with desloratadine in the treatment of common vulgaris acne in vietnamese patients.
Open Access Maced J Med Sci. 2019;7(2):217-220. doi:
10.3889/oamjms.2019.054PubMedGoogle ScholarCrossref 169.Rassai
S , Mehri
M , Yaghoobi
R , Sina
N , Mohebbipour
A , Feily
A . Superior efficacy of azithromycin and levamisole vs. azithromycin in the treatment of inflammatory acne vulgaris: an investigator blind randomized clinical trial on 169 patients.
Int J Clin Pharmacol Ther. 2013;51(6):490-494. doi:
10.5414/CP201861PubMedGoogle ScholarCrossref 170.Dhawan
SS , Gwazdauskas
J . Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Cutis. 2013;91(2):99-104.
PubMedGoogle Scholar 171.Draelos
ZD , Elewski
BE , Harper
JC ,
et al. A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.
Cutis. 2015;96(1):54-61.
PubMedGoogle Scholar 172.Draelos
ZD , Elewski
B , Staedtler
G , Havlickova
B . Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.
Cutis. 2013;92(6):306-317.
PubMedGoogle Scholar 173.Draelos
ZD , Shalita
AR , Thiboutot
D , Oresajo
C , Yatskayer
M , Raab
S . A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Cutis. 2012;89(6):287-293.
PubMedGoogle Scholar 174.Martel
P , Jarratt
M , Weiss
J , Carlavan
I . Lack of significant anti-inflammatory activity with clindamycin in the treatment of rosacea: results of 2 randomized, vehicle-controlled trials.
Cutis. 2017;100(1):53-58.
PubMedGoogle Scholar 175.Solomon
JA , Tyring
S , Staedtler
G , Sand
M , Nkulikiyinka
R , Shakery
K . Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.
Cutis. 2016;98(3):187-194.
PubMedGoogle Scholar 176.Mokhtari
F , Gholami
M , Siadat
AH ,
et al. Efficacy of intense-pulsed light therapy with topical benzoyl peroxide 5% versus benzoyl peroxide 5% alone in mild-to-moderate acne vulgaris: a randomized controlled trial.
J Res Pharm Pract. 2017;6(4):199-205. doi:
10.4103/jrpp.JRPP_17_29PubMedGoogle ScholarCrossref 177.Mehran
G , Sepasgozar
S , Rohaninasab
M ,
et al. Comparison between the therapeutic effect of microneedling versus tretinoin in patients with comedonal acne: a randomized clinical trial.
Iran J Dermatol. 2019;22(3):87-91. doi:
10.22034/IJD.2019.100199Google Scholar 178.Moravvej
H , Mousazadeh Halim
A , Yousefi
M , Givrad
S . Efficacy of doxycycline versus azithromycin in the treatment of moderate facial acne vulgaris.
Iran J Dermatol. 2012;15(1):7-10.
Google Scholar 179.Sugat
AJ , Vaidehi
AS , Ambika
RK . Efficacy and tolerability of adapalene 0.1%-benzoyl peroxide 2.5% combination gel in treatment of acne vulgaris in Indian patients: a randomized investigator-blind controlled trial.
Iran J Dermatol. 2016;19(4):105-112.
Google Scholar 180.Faghihi
G , Rakhshanpour
M , Abtahi-Naeini
B , Nilforoushzadeh
MA . The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study.
Adv Biomed Res. 2014;3(1):177. doi:
10.4103/2277-9175.139413PubMedGoogle ScholarCrossref 181.Fatemi
F , Najafian
J , Nasab
SS , Nilforoushzadeh
MA . Treatment of acne vulgaris using the combination of topical erythromycin and miconazole.
J Skin Stem Cell. 2014;1(3):23330. doi:
10.17795/jssc23330Google ScholarCrossref 182.Khorvash
F , Abdi
F , Kashani
HH , Fatemi Naeini
F , Khorvash
F . Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.
Iran J Pharm Res. 2013;12(1):223-227.
PubMedGoogle Scholar 183.Gurung
S , Patil
N , Rao
K ,
et al. A comparative study on efficacy of azithromycin and doxycycline in the treatment of acne vulgaris at a tertiary care centre.
Biomed Pharmacol J. 2020;13(3):1451-1455. doi:
10.13005/bpj/2016Google ScholarCrossref 184.Hussain
S , Mustafa
A , Mumtaz
A , Soban
M , Shaheen
G , Ahmad
S . Comparison of efficacy of azithromycin and levamisole in combination with azithromycin in patients of moderate to severe acne.
Pak J Med Health Sci. 2021;15(9):2444-2446. doi:
10.53350/pjmhs211592444Google ScholarCrossref 185.Anjum
K , Altaf
F , Shahzadi
N , Nabi
H , Jafri
M , Tahir
Z . Comparison of efficacy of 0.1% tazarotene versus 0.1% adapalene for the treatment of mild acne vulgaris.
Pak J Med Health Sci. 2020;14(1):63-66.
Google Scholar 186.Kabir
M , Sadiq
S , Raza
A , Kanwal
S , Tanvir
T . Comparison of efficacy of adapalene (0.1% gel) monotherapy ve adapalene (0.1%) plus benzyl peroxide (2.5%) combination therapy for treatment of mild to moderate acne vulgaris.
Pak J Med Health Sci. 2018;12(2):587-589.
Google Scholar 187.Mahmoudi
M , Hajheydari
Z , Vahidshahi
K , Nozari
A . Comparison of efficacy of azithromycin vs. clindamycin and erythromycin in the treatment of mild to moderate acne vulgaris.
Pak J Med Sci. 2011;27(1):68-72.
Google Scholar 188.Pandey
D , Agrawal
S . Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne: a randomised control trial.
Kathmandu Univ Med J (KUMJ). 2019;17(65):14-19. KUMJ.
PubMedGoogle Scholar 189.Paracha
MM , Zahoor
H , Afridi
I , Kammal
K . Efficacy and safety of short term use of 0.1% tazarotene gel in the treatment of mild to moderate acne vulgaris: a randomized-vehicle controlled trial.
J Postgrad Med Inst. 2020;34(2).
Google Scholar 190.Özgen
Z , Gürbüz
O . A randomized, double-blind comparison of nadifloxacin 1% cream alone and with benzoyl peroxide 5% lotion in the treatment of mild to moderate facial acne vulgaris.
Marmara Med J. 2013;26:17-20.
Google Scholar 192.Zaib
D , Naqvi
F , Rashid
S , Inayat
S , Ilyas
A , Faraz
AAK . To assess the efficacy of isotretinoin in acne vulgaris with daily versus pulse therapy.
J Pak Assoc Dermatol. 2020;30(2):271-276.
Google Scholar 193.Hafeez
L , Khan
AN , Aslam
A , Tahir
R , Shafi
A , Akhtar
A . Comparison of safety and efficacy of low dose isotretinoin versus the conventional dosing regime in the treatment of acne vulgaris.
J Pak Assoc Dermatol. 2020;30(3):423-427.
Google Scholar 194.Khan
M , Khan
NU , Anwar
MI , Noor
SM . A comparison of the efficacy of topical adapalene gel 0.1% with tretinoin gel 0.025% in mild acne vulgaris.
J Pak Assoc Dermatol. 2017;27(1):37-41.
Google Scholar 195.Mohammadi
S , Farajzadeh
S , Pardakhti
A ,
et al. A survey to compare the efficacy of niosomal erythromycin alone versus combination of erythromycin and zinc acetate in the treatment of acne vulgaris.
J Kerman Univ Med Sci. 2017;24(5):420-430.
Google Scholar 196.Üstüner
P , Güleç
AT , Demirbilek
M . Clinical and bacteriological evaluation of nadifloxacin 1% cream versus erythromycin 4% gel in the treatment of mild-to-moderate facial acne vulgaris: a randomized study.
Turk Klin Tip Bilim Derg. 2015;35(2):97-105. doi:
10.5336/medsci.2015-43531Google ScholarCrossref 198.Afzali
BM , Yaghoobi
E , Yaghoobi
R , Bagherani
N , Dabbagh
MA . Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
J Dermatolog Treat. 2012;23(1):21-25. doi:
10.3109/09546634.2010.488260PubMedGoogle ScholarCrossref 199.Ahmadvand
A , Yazdanfar
A , Yasrebifar
F , Mohammadi
Y , Mahjub
R , Mehrpooya
M . Evaluating the effects of oral and topical simvastatin in the treatment of acne vulgaris: a double-blind, randomized, placebo-controlled clinical trial.
Curr Clin Pharmacol. 2018;13(4):279-283. doi:
10.2174/1574884713666180821143545PubMedGoogle ScholarCrossref 200.Khodaeinai
E , Babaeinejad
S , Amirnia
M ,
et al. Efficacy of 10% azelaic acid gel with hydro-alcoholic or alcohol-free bases in mild to moderate acne vulgaris: the first clinical trial.
J Med Sci (Faisalabad). 2014;14(2):87-91. doi:
10.3923/jms.2014.87.91Google ScholarCrossref 201.Ullah
G , Noor
SM , Bhatti
Z , Ahmad
M , Bangash
AR . Comparison of oral azithromycin with oral doxycycline in the treatment of acne vulgaris.
J Ayub Med Coll Abbottabad. 2014;26(1):64-67.
PubMedGoogle Scholar 202.Maleszka
R , Turek-Urasinska
K , Oremus
M , Vukovic
J , Barsic
B . Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study.
Skinmed. 2011;9(2):86-94.
PubMedGoogle Scholar 203.Montes
LF , Wilborn
WH , Montes
CM . Topical acne treatment with acetylcysteine: clinical and experimental effects.
Skinmed. 2012;10(6):348-351.
PubMedGoogle Scholar 204.Jurairattanaporn
N , Chalermchai
T , Ophaswongse
S , Udompataikul
M . Comparative trial of silver nanoparticle gel and 1% clindamycin gel when use in combination with 2.5% benzoyl peroxide in patients with moderate acne vulgaris.
J Med Assoc Thai. 2017;100(1):78-85.
PubMedGoogle Scholar 205.Webster
GF , Sugarman
J , Levy-Hacham
O , Toledano
O . Microencapsulated benzoyl peroxide and tretinoin for the treatment of acne vulgaris: results from a phase 2 multicenter, double-blind, randomized, vehicle-controlled study.
Skinmed. 2020;18(6):343-351.
PubMedGoogle Scholar 207.Feldman
SR , Regnier
SA , Chirilov
A , Hey
F , Gilloteau
I , Cella
D . Patient-reported outcomes are important elements of psoriasis treatment decision making: a discrete choice experiment survey of dermatologists in the United States.
J Am Acad Dermatol. 2019;80(6):1650-1657. doi:
10.1016/j.jaad.2019.01.039
PubMedGoogle ScholarCrossref 209.Barbieri
JS , Gelfand
JM . Responsiveness of the EuroQol 5-dimension 3-level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the USA.
Br J Dermatol. 2019;181(5):1088-1090. doi:
10.1111/bjd.18142
PubMedGoogle ScholarCrossref